Propafenone poisoning-A case report with plasma propafenone concentrations

Journal of Medical Toxicology

Volumn 6, Issue 1, 2010, Pages 37-40

  Ovaska, Hanna ^a   Ludman, Andrew ^b   Spencer, Edgar P ^a   Wood, David M ^c,d   Jones, Alison L ^e   Dargan, Paul I ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cardiogenic shock; Convulsions; Poisoning; Propafenone

Indexed keywords

5 HYDROXYPROPAFENONE; ACTIVATED CARBON; ADRENALIN; ATROPINE; BICARBONATE; CARBAMAZEPINE; GLUCAGON; LORAZEPAM; MAGNESIUM SULFATE; PROPAFENONE;

ABSENCE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CARDIOTOXICITY; CARDIOVERSION; CASE REPORT; COMA; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; ELECTROCARDIOGRAM; GLASGOW COMA SCALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTENSION; LABORATORY TEST; MALE; QRS COMPLEX; QT PROLONGATION; RESUSCITATION; SEIZURE; TONIC CLONIC SEIZURE; ULTRAVIOLET SPECTROSCOPY; VOMITING;

ANTI-ARRHYTHMIA AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMA; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; OVERDOSE; POISONING; PROPAFENONE; SEIZURES; SHOCK, CARDIOGENIC; SPECTROPHOTOMETRY, ULTRAVIOLET; TREATMENT OUTCOME;

EID: 77951938956     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0037-2     Document Type: Article

References (19)

1. National Institute for Health and Clinical Excellence (2006) NICE clinical guideline 36-atrial fibrillation: the management of atrial fibrillation. http://www.nice.org.uk/nicemedia/pdf/CG036nice guideline.pdf. Accessed 30 Jan 2009
2. Anon (1999) Propafenone (hydrochloride). In: Dollery C, Boobis A (eds) Therapeutics and drugs, 2nd edn. Churchill Livingstone Inc, London, pp 243-248
3. Afshar M, Thormann W (2006) Capillary electrophoretic investigation of the enantioselective metabolism of propafenone by human cytochrome P-450 SUPERSOMES: evidence for atypical kinetics by CYP2D6 and CYP3A4. Electrophoresis 27:1526-1536
4. Cahill SA, Gross GJ (2004) Propafenone and its metabolites preferentially inhibit IKr in rabbit ventricular myocytes. J Pharmacol Exp Ther 308:59-65
5. Siddoway LA, Roden DM, Woosley RL (1984) Clinical pharmacology of propafenone: pharmacokinetics, metabolism and concentration-response. Am J Cardiol 54:9D-12D
6. Connolly SJ, Kates RE, Lebsack CS, Harrison DC, Winkle RA (1983) Clinical pharmacology of propafenone. Circulation 68:589-596
7. CYP2D6 Allele Nomenclature (2008) http://www.cypalleles.ki.se/ cyp2d6.htm. Accessed 30 Jan 2009
8. Pirmohamed M, Park BK (2003) Cytochrome P450 enzyme polymorphism and adverse drug reactions. Toxicology 192:23-32
9. Evans DA, Mahgoub A, Sloan TP, Idle JR, Smith RL (1980) A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet 17:102-105
10. Steiner E, Iselius L, Alván G, Lindsten J, Sjöqvist F (1985) A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquine. Clin Pharm Ther 38:394-401
11. Fonck K, Haenebalcke C, Hemeryck A, Belpaire F, Jordaens L, Calle P, Buylaert W (1998) ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning. J Toxicol Clin Toxicol 36:247-251
12. Keyler DE, Pentel PR (1989) Hypertonic sodium bicarbonate partially reverses QRS prolongation due to flecainide in rats. Life Sci 45:1575-1580
13. Clarot F, Goullé JP, Horst M, Vaz E, Lacroix C, Proust B (2003) Fatal propafenone overdoses: case reports and a review of the literature. J Anal Toxicol 27:595-599
14. Eray O, Fowler J (2000) Severe propafenone poisoning responded to temporary internal pacemaker. Vet Hum Toxicol 42:289
15. Kerns W, English B, Ford M (1994) Propafenone overdose. Ann Emerg Med 24:98-103
16. Rambourg-Schepens MO, Grossenbacher F, Buffet M, Lamiable D (1999) Recurrent convulsions and cardiac conduction disturbances after propafenone overdose. Vet Hum Toxicol 41:153
17. Hasdemir C, Olukman M, Ulucan C, Roden DM (2006) Brugadatype ECG pattern and extreme QRS complex widening with propafenone overdose. J Cardiovasc Electrophysiol 17:565-566
18. Siddoway LA, Thompson KA, McAllister CB, Wang T, Wilkinson GR, Roden DM, Woosley RL (1987) Circulation polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. Circulation 75:785-791
19. Lee JT, Lineberry MD, Funck-Bretano C (1988) Propafenone induced beta-blockade in extensive and poor metaboliser subjects. Circulation 78:499